Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis

As a part of our project aimed at the search for new safe chemotherapeutic and chemoprophylactic agents against American trypanosomiasis (Chagas's disease); a series of phosphinopeptides structurally related to glutathione was designed, synthesized, and evaluated as antiproliferative agents aga...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ravaschino, E.L., Docampo, R., Rodriguez, J.B.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_00222623_v49_n1_p426_Ravaschino
Aporte de:
id todo:paper_00222623_v49_n1_p426_Ravaschino
record_format dspace
spelling todo:paper_00222623_v49_n1_p426_Ravaschino2023-10-03T14:30:15Z Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis Ravaschino, E.L. Docampo, R. Rodriguez, J.B. 1 butyl [[(gamma glutamylleucyl)amino]methyl]phosphinate 1 pentyl [[(gamma glutamylleucyl)amino]methyl]phosphinate phosphinic acid derivative trypanothione unclassified drug amastigote antiprotozoal activity article Chagas disease drug design drug efficacy drug structure drug synthesis myoblast pharmacophore Trypanosoma cruzi Amide Synthases Animals Antiprotozoal Agents Cell Proliferation Drug Design Glutathione Molecular Structure Parasitic Sensitivity Tests Peptides Phenyl Ethers Phosphinic Acids Spermidine Structure-Activity Relationship Thiocyanates Trypanosoma cruzi As a part of our project aimed at the search for new safe chemotherapeutic and chemoprophylactic agents against American trypanosomiasis (Chagas's disease); a series of phosphinopeptides structurally related to glutathione was designed, synthesized, and evaluated as antiproliferative agents against the parasite responsible for this disease, the hemoflagellated protozoan Trypanosoma cruzi. The rationale for the synthesis of these compounds was supported on the basis that the presence of the phosphinic acid moiety would mimic the tetrahedral transition state of trypanothione synthase (TryS), a typical C:N ligase, and the molecular target of these drugs. Of the designed compounds, 53 and 54 were potent growth inhibitors against the clinically more relevant form of T. cruzi (amastigotes) growing in myoblasts. The efficacy for these drugs was comparable to that exhibited by the well-known antiparasitic agent WC-9. The simple phosphinopeptide structure found as a pharmacophore in the present study constitutes a starting point for the development of straightforward optimized drugs. © 2006 American Chemical Society. Fil:Ravaschino, E.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Rodriguez, J.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00222623_v49_n1_p426_Ravaschino
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 1 butyl [[(gamma glutamylleucyl)amino]methyl]phosphinate
1 pentyl [[(gamma glutamylleucyl)amino]methyl]phosphinate
phosphinic acid derivative
trypanothione
unclassified drug
amastigote
antiprotozoal activity
article
Chagas disease
drug design
drug efficacy
drug structure
drug synthesis
myoblast
pharmacophore
Trypanosoma cruzi
Amide Synthases
Animals
Antiprotozoal Agents
Cell Proliferation
Drug Design
Glutathione
Molecular Structure
Parasitic Sensitivity Tests
Peptides
Phenyl Ethers
Phosphinic Acids
Spermidine
Structure-Activity Relationship
Thiocyanates
Trypanosoma cruzi
spellingShingle 1 butyl [[(gamma glutamylleucyl)amino]methyl]phosphinate
1 pentyl [[(gamma glutamylleucyl)amino]methyl]phosphinate
phosphinic acid derivative
trypanothione
unclassified drug
amastigote
antiprotozoal activity
article
Chagas disease
drug design
drug efficacy
drug structure
drug synthesis
myoblast
pharmacophore
Trypanosoma cruzi
Amide Synthases
Animals
Antiprotozoal Agents
Cell Proliferation
Drug Design
Glutathione
Molecular Structure
Parasitic Sensitivity Tests
Peptides
Phenyl Ethers
Phosphinic Acids
Spermidine
Structure-Activity Relationship
Thiocyanates
Trypanosoma cruzi
Ravaschino, E.L.
Docampo, R.
Rodriguez, J.B.
Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis
topic_facet 1 butyl [[(gamma glutamylleucyl)amino]methyl]phosphinate
1 pentyl [[(gamma glutamylleucyl)amino]methyl]phosphinate
phosphinic acid derivative
trypanothione
unclassified drug
amastigote
antiprotozoal activity
article
Chagas disease
drug design
drug efficacy
drug structure
drug synthesis
myoblast
pharmacophore
Trypanosoma cruzi
Amide Synthases
Animals
Antiprotozoal Agents
Cell Proliferation
Drug Design
Glutathione
Molecular Structure
Parasitic Sensitivity Tests
Peptides
Phenyl Ethers
Phosphinic Acids
Spermidine
Structure-Activity Relationship
Thiocyanates
Trypanosoma cruzi
description As a part of our project aimed at the search for new safe chemotherapeutic and chemoprophylactic agents against American trypanosomiasis (Chagas's disease); a series of phosphinopeptides structurally related to glutathione was designed, synthesized, and evaluated as antiproliferative agents against the parasite responsible for this disease, the hemoflagellated protozoan Trypanosoma cruzi. The rationale for the synthesis of these compounds was supported on the basis that the presence of the phosphinic acid moiety would mimic the tetrahedral transition state of trypanothione synthase (TryS), a typical C:N ligase, and the molecular target of these drugs. Of the designed compounds, 53 and 54 were potent growth inhibitors against the clinically more relevant form of T. cruzi (amastigotes) growing in myoblasts. The efficacy for these drugs was comparable to that exhibited by the well-known antiparasitic agent WC-9. The simple phosphinopeptide structure found as a pharmacophore in the present study constitutes a starting point for the development of straightforward optimized drugs. © 2006 American Chemical Society.
format JOUR
author Ravaschino, E.L.
Docampo, R.
Rodriguez, J.B.
author_facet Ravaschino, E.L.
Docampo, R.
Rodriguez, J.B.
author_sort Ravaschino, E.L.
title Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis
title_short Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis
title_full Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis
title_fullStr Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis
title_full_unstemmed Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis
title_sort design, synthesis, and biological evaluation of phosphinopeptides against trypanosoma cruzi targeting trypanothione biosynthesis
url http://hdl.handle.net/20.500.12110/paper_00222623_v49_n1_p426_Ravaschino
work_keys_str_mv AT ravaschinoel designsynthesisandbiologicalevaluationofphosphinopeptidesagainsttrypanosomacruzitargetingtrypanothionebiosynthesis
AT docampor designsynthesisandbiologicalevaluationofphosphinopeptidesagainsttrypanosomacruzitargetingtrypanothionebiosynthesis
AT rodriguezjb designsynthesisandbiologicalevaluationofphosphinopeptidesagainsttrypanosomacruzitargetingtrypanothionebiosynthesis
_version_ 1807316333881196544